QIAO Jian-jun, ZHANG Hong. Analysis on Partial Sequence of ERG11 Promoter Region of Candida albicans[J].Chinese Journal of Dermatology, 2005, 38(3): 160-162.
[1] White TC,Pfaller MA,Rinaldi MG,et al.Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient.Oral Dis,1997,3 (Suppl 1);102-109. [2] Redding S,Smith J,Farinacci G,et al.Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS;documentation by in vitro susceptibility testing and DNA subtype analysis.Clin Infect Dis,1994,18;240-242. [3] 石婧,张宏.白念珠菌菌丝相和酵母相ERG11基因部分序列差异性的探讨.中华皮肤科杂志,2004,37;472-474. [4] Choi W,Yoo YJ,Kim M,et al.Identification of proteins highly ex-pressed in the hypha of Candida albicans by two-dimensional electrophoresis.Yeast,2003,20;1053-1060. [5] 李晋波,刘维达.特比萘芬对白念珠菌酵母相和菌丝相抗菌活性的比较.中华皮肤科杂志,2000,33;53-54. [6] White TC.Increased mRNA levels of ERG16,CDR,and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.Antimicrob Agents Chemother,1997,41;1482-1487. [7] White TC.The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans.Antimicrob Agents Chemother,1997,41;1488-1494.